• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩张型心肌病患者不同程度舒张功能障碍时纤维化相关血清标志物的动力学变化。

Kinetics of selected serum markers of fibrosis in patients with dilated cardiomyopathy and different grades of diastolic dysfunction of the left ventricle.

机构信息

Collegium Medicum of Jagiellonian University, Department of Cardiac and Vascular Diseases, John Paul II Hospital, Kraków, Poland, ul.Prądnicka 80, 31-202 Cracow, Poland.

Department of Molecular Biology, John Paul II Hospital, Krakow, Poland, ul. Prądnicka 80, 31-202 Cracow, Poland.

出版信息

Cardiol J. 2020;27(6):726-734. doi: 10.5603/CJ.a2018.0143. Epub 2018 Nov 28.

DOI:10.5603/CJ.a2018.0143
PMID:30484268
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8079113/
Abstract

BACKGROUND

Fibrosis of the extracellular matrix (ECM) in dilated cardiomyopathy (DCM) is common and compromises both systolic and diastolic function. The aim of this study was to investigate the kinetics of ECM fibrosis markers over a 12 month follow-up in patients with DCM based on the severity of diastolic dysfunction (DD).

METHODS

Seventy consecutive DCM patients (48 ± 12.1 years, ejection fraction 24.4 ± 7.4%) were included in the study. The grade of DD was determined using the ASE/EACVI algorithm. Markers of ECM fibrosis were measured at baseline and at 3 and 12 month follow-ups: collagen type I and III (PICP, PINP, PIIICP, PIIINP), transforming growth factor beta-1 (TGF1-b), connective tissue growth factor (CTGF) and galectin-3 were measured.

RESULTS

Patients were divided into three groups according to DD severity: 30 patients with grade I, 18 with grade II and 22 with grade III of DD. Levels of PICP, PINP were increased over a 12-month period, while PIIINP decreased and PIIICP unchanged. Levels of TGF1-b decreased from the 3 to the 12-month points in grade I and II DD, and in grade III they remained unchanged. Levels of CTGF decreased over 12 months in grade III DD but were unchanged in grades I and II. Galectin-3 levels remained the same over all observation periods, irrespective of DD grade.

CONCLUSIONS

Regardless of the DD grade, markers of collagen type I synthesis increased, markers of collagen type III decreased. Levels of TGF and CTGF had a tendency to decrease. Galectin-3 was revealed not to be a marker discriminating the severity of DD.

摘要

背景

扩张型心肌病(DCM)的细胞外基质(ECM)纤维化很常见,会影响收缩和舒张功能。本研究旨在根据舒张功能障碍(DD)的严重程度,研究 DCM 患者在 12 个月随访期间 ECM 纤维化标志物的动力学。

方法

连续纳入 70 例 DCM 患者(48 ± 12.1 岁,射血分数 24.4 ± 7.4%)。采用 ASE/EACVI 算法确定 DD 程度。在基线和 3 个月及 12 个月随访时测量 ECM 纤维化标志物:Ⅰ型和Ⅲ型胶原(PICP、PINP、PIIICP、PIIINP)、转化生长因子β-1(TGF1-b)、结缔组织生长因子(CTGF)和半乳糖凝集素-3。

结果

根据 DD 严重程度将患者分为三组:30 例 DD Ⅰ级,18 例 DD Ⅱ级,22 例 DD Ⅲ级。PICP、PINP 在 12 个月期间升高,而 PIIINP 降低,PIIICP 不变。DD Ⅰ级和Ⅱ级患者 TGF1-b 水平在 3 个月至 12 个月期间下降,而 DD Ⅲ级患者无变化。DD Ⅲ级 CTGF 水平在 12 个月内下降,但 DD Ⅰ级和Ⅱ级无变化。Galectin-3 在所有观察期内保持不变,与 DD 分级无关。

结论

无论 DD 分级如何,Ⅰ型胶原合成标志物增加,Ⅲ型胶原标志物减少。TGF 和 CTGF 水平有下降趋势。Galectin-3 不是区分 DD 严重程度的标志物。

相似文献

1
Kinetics of selected serum markers of fibrosis in patients with dilated cardiomyopathy and different grades of diastolic dysfunction of the left ventricle.扩张型心肌病患者不同程度舒张功能障碍时纤维化相关血清标志物的动力学变化。
Cardiol J. 2020;27(6):726-734. doi: 10.5603/CJ.a2018.0143. Epub 2018 Nov 28.
2
12-month patterns of serum markers of collagen synthesis, transforming growth factor and connective tissue growth factor are similar in new-onset and chronic dilated cardiomyopathy in patients both with and without cardiac fibrosis.在伴有和不伴有心脏纤维化的患者中,新发和慢性扩张型心肌病患者血清中胶原蛋白合成、转化生长因子和结缔组织生长因子标志物的12个月变化模式相似。
Cytokine. 2017 Aug;96:217-227. doi: 10.1016/j.cyto.2017.04.021. Epub 2017 Apr 28.
3
Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.细胞外基质纤维化与疾病持续时间有关,但与扩张型心肌病中胶原代谢的动态变化无关。
Inflamm Res. 2016 Dec;65(12):941-949. doi: 10.1007/s00011-016-0977-3. Epub 2016 Aug 11.
4
Prognostic value of fibrosis-related markers in dilated cardiomyopathy: A link between osteopontin and cardiovascular events.扩张型心肌病中纤维化相关标志物的预后价值:骨桥蛋白与心血管事件之间的联系
Adv Med Sci. 2018 Mar;63(1):160-166. doi: 10.1016/j.advms.2017.10.004. Epub 2017 Nov 6.
5
Relationships between circulating galectin-3, extracellular matrix fibrosis and outcomes in dilated cardiomyopathy.循环半乳糖凝集素-3、细胞外基质纤维化与扩张型心肌病患者预后的关系。
Adv Clin Exp Med. 2021 Mar;30(3):245-253. doi: 10.17219/acem/115081.
6
Right ventricular morphology and function is not related with microRNAs and fibrosis markers in dilated cardiomyopathy.在扩张型心肌病中,右心室形态和功能与微小RNA及纤维化标志物无关。
Cardiol J. 2018;25(6):722-731. doi: 10.5603/CJ.a2017.0099. Epub 2017 Aug 25.
7
Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR.在扩张型心肌病中,无论左心室逆向重构(LVRR)的定义如何,左心室逆向重构均与活检检测到的细胞外基质纤维化及纤维化血清标志物无关。
Heart Vessels. 2017 Jun;32(6):714-725. doi: 10.1007/s00380-016-0930-y. Epub 2016 Dec 21.
8
Impact of Baseline Left Ventricular Diastolic Dysfunction in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术治疗重度主动脉瓣狭窄患者的基线左心室舒张功能障碍的影响。
Am J Cardiol. 2020 Jan 15;125(2):258-263. doi: 10.1016/j.amjcard.2019.10.016. Epub 2019 Oct 30.
9
Circulating markers of collagen types I, III, and IV in patients with dilated cardiomyopathy: relationships with myocardial collagen expression.扩张型心肌病患者循环型 I、III、IV 型胶原标志物:与心肌胶原表达的关系。
ESC Heart Fail. 2018 Dec;5(6):1044-1051. doi: 10.1002/ehf2.12360. Epub 2018 Oct 1.
10
Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy.黄芪甲苷通过抑制柯萨奇病毒 B3 诱导的心肌病中的 TGF-β1 信号通路减轻心肌纤维化。
Eur J Pharmacol. 2011 May 11;658(2-3):168-74. doi: 10.1016/j.ejphar.2011.02.040. Epub 2011 Mar 1.

引用本文的文献

1
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).骨转换标志物在骨质疏松症诊断和管理中的作用更新:来自欧洲骨质疏松症、骨关节炎和肌肉骨骼疾病临床与经济学会(ESCEO)、国际骨质疏松症基金会(IOF)以及国际临床化学和检验医学联合会(IFCC)的共识文件。
Osteoporos Int. 2025 Apr;36(4):579-608. doi: 10.1007/s00198-025-07422-3. Epub 2025 Mar 28.
2
Circulating collagen type I fragments as specific biomarkers of cardiovascular outcome risk: Where are the opportunities?循环I型胶原片段作为心血管结局风险的特异性生物标志物:机遇何在?
Matrix Biol. 2025 May;137:19-32. doi: 10.1016/j.matbio.2025.03.001. Epub 2025 Mar 2.
3
Association of fibrotic markers with diastolic function after STEMI.纤维化标志物与 STEMI 后舒张功能的相关性。
Sci Rep. 2024 Aug 18;14(1):19122. doi: 10.1038/s41598-024-69926-y.
4
Blocking CCN2 Reduces Established Bone Loss Induced by Prolonged Intense Loading by Increasing Osteoblast Activity in Rats.通过增强大鼠成骨细胞活性,阻断CCN2可减轻长期高强度负荷诱导的已形成的骨质流失。
JBMR Plus. 2023 Jun 16;7(9):e10783. doi: 10.1002/jbm4.10783. eCollection 2023 Sep.
5
An Robust Rank Aggregation and Least Absolute Shrinkage and Selection Operator Analysis of Novel Gene Signatures in Dilated Cardiomyopathy.扩张型心肌病中新型基因特征的稳健秩聚合及最小绝对收缩和选择算子分析
Front Cardiovasc Med. 2021 Dec 14;8:747803. doi: 10.3389/fcvm.2021.747803. eCollection 2021.
6
Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.左旋肉碱治疗扩张型心肌病的疗效:一项随机对照试验的荟萃分析。
Biomed Res Int. 2021 Jan 12;2021:9491615. doi: 10.1155/2021/9491615. eCollection 2021.
7
Diastolic dyssynchrony and its exercise-induced changes affect exercise capacity in patients with heart failure with reduced ejection fraction.舒张期不同步及其运动诱发的变化会影响射血分数降低的心力衰竭患者的运动能力。
Cardiol J. 2021;28(6):932-940. doi: 10.5603/CJ.a2019.0032. Epub 2019 Apr 17.

本文引用的文献

1
Right ventricular morphology and function is not related with microRNAs and fibrosis markers in dilated cardiomyopathy.在扩张型心肌病中,右心室形态和功能与微小RNA及纤维化标志物无关。
Cardiol J. 2018;25(6):722-731. doi: 10.5603/CJ.a2017.0099. Epub 2017 Aug 25.
2
12-month patterns of serum markers of collagen synthesis, transforming growth factor and connective tissue growth factor are similar in new-onset and chronic dilated cardiomyopathy in patients both with and without cardiac fibrosis.在伴有和不伴有心脏纤维化的患者中,新发和慢性扩张型心肌病患者血清中胶原蛋白合成、转化生长因子和结缔组织生长因子标志物的12个月变化模式相似。
Cytokine. 2017 Aug;96:217-227. doi: 10.1016/j.cyto.2017.04.021. Epub 2017 Apr 28.
3
Plasma and Cardiac Galectin-3 in Patients With Heart Failure Reflects Both Inflammation and Fibrosis: Implications for Its Use as a Biomarker.心力衰竭患者血浆和心脏半乳糖凝集素-3反映炎症和纤维化:其作为生物标志物的意义
Circ Heart Fail. 2017 Mar;10(3). doi: 10.1161/CIRCHEARTFAILURE.116.003804.
4
The differences in the relationship between diastolic dysfunction, selected biomarkers and collagen turn-over in heart failure patients with preserved and reduced ejection fraction.射血分数保留和降低的心力衰竭患者舒张功能障碍、选定生物标志物与胶原周转之间关系的差异。
Cardiol J. 2017;24(1):35-42. doi: 10.5603/CJ.a2016.0098. Epub 2016 Oct 17.
5
Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.细胞外基质纤维化与疾病持续时间有关,但与扩张型心肌病中胶原代谢的动态变化无关。
Inflamm Res. 2016 Dec;65(12):941-949. doi: 10.1007/s00011-016-0977-3. Epub 2016 Aug 11.
6
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗特别工作组。由ESC心力衰竭协会(HFA)特别贡献制定。
Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20.
7
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.超声心动图评估左心室舒张功能的建议:美国超声心动图学会和欧洲心血管影像学会的更新
J Am Soc Echocardiogr. 2016 Apr;29(4):277-314. doi: 10.1016/j.echo.2016.01.011.
8
Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices.利用细胞和动物模型以及临床指标研究半乳糖凝集素-3水平与心脏舒张功能障碍的严重程度。
Sci Rep. 2015 Nov 19;5:17007. doi: 10.1038/srep17007.
9
Galectin-3 as a new biomarker of diastolic dysfunction in hemodialysis patients.半乳糖凝集素-3作为血液透析患者舒张功能障碍的新型生物标志物
Herz. 2015 Aug;40(5):788-94. doi: 10.1007/s00059-015-4303-6. Epub 2015 May 20.
10
Genetic Analysis of Connective Tissue Growth Factor as an Effector of Transforming Growth Factor β Signaling and Cardiac Remodeling.结缔组织生长因子作为转化生长因子β信号传导和心脏重塑效应因子的遗传分析
Mol Cell Biol. 2015 Jun;35(12):2154-64. doi: 10.1128/MCB.00199-15. Epub 2015 Apr 13.